HealthContentAdvisors

PharmaVentures Launches Database of Pharma Deals

• Posted July 14th 2008
• by Marji

Transaction advisory and media company PharmaVentures, has launched PharmaDeals v2, a database of deals and alliances for the pharmaceutical sector. The new database is an extension of the PharmaDeals database that has served pharmaceutical and biotechnology companies, law firms, financial institutions and universities for the past 12 years.

Using feedback from customers, PharmaVentures, introduced new features in this latest version of its database. PharmaDeals v2 has several applications, including the benchmarking of deals, analyzing competitor activity, tracking development of particular deals and investigating the landscape of emerging deals and alliances. The database has a new user interface and an improved search function that helps users wade through information related to more than 28,000 deals.

New features include mapping of pharmaceutical products according to the recognized, international classification of diseases, as well as an enhanced classification of product types and a rigorous classification of license territories. There are also new personalization features, such as a watch list and associated email alerting service. Customers can also access the database through several delivery methods, including IP domain-authenticated access and xml feeds.

PharmaDeals v2 subscribers will also receive access to PharmaDeals Review, an online publication and article archive that provides users with intelligence to compliment the data records they receive from the database. The publication contains articles about deals news and contributed feature articles from industry writers. Subscribers can also access recent and archived videos from PharmaTelevision, PharmaVentures’ online TV channel.

There is certainly a lot to like about the new PharmaDeals database. While the original product had more than a decade of success, it’s clear that PharmaVentures realized the need to supply its customer base with a more robust offering. Of course, the data is important. But the addition new functionality, as well as a collection of personalization features, is crucial for any database product today. The more relevant you can make such a product for your customers, the better. By communicating with customers to determine what they wanted from a new database product undoubtedly helped PharmaVentures get–and stay–on the right track with this new initiative.

Providing access to PharmaDeals Review and PharmaTelevision also help PharmaVentures provide the value-added services that customers also expect.